Systematic review of mutations associated with resistance to the new and repurposedMycobacterium tuberculosisdrugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid | Zendy

Suha Kadura | Zendy; Nicholas King | Zendy; Maria Nakhoul | Zendy; Hongya Zhu | Zendy; Grant Theron | Zendy; Claudio U. Köser | Zendy; Maha Farhat | Zendy

Open Access

Systematic review of mutations associated with resistance to the new and repurposedMycobacterium tuberculosisdrugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid

Author(s) -

Suha Kadura,

Nicholas King,

Maria Nakhoul,

Hongya Zhu,

Grant Theron,

Claudio U. Köser,

Maha Farhat

Publication year - 2020

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkaa136

Subject(s) - bedaquiline , clofazimine , linezolid , mycobacterium tuberculosis , tuberculosis , microbiology and biotechnology , medicine , biology , bacteria , staphylococcus aureus , immunology , vancomycin , genetics , leprosy , pathology

Improved genetic understanding of Mycobacterium tuberculosis (MTB) resistance to novel and repurposed anti-tubercular agents can aid the development of rapid molecular diagnostics.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research